Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 49 publications
Novel BRAF fusion in Erdheim-Chester disease with pulmonary manifestations: Importance of RNA-based testing and response to MEK inhibition.
Journal: Histopathology
Published: April 01, 2026
Single-center experience with nelarabine, etoposide, and cyclophosphamide in adults with relapsed/refractory T-acute lymphoblastic leukemia/lymphoma.
Journal: Leukemia & lymphoma
Published: May 07, 2025
A phase 1 trial of ibrutinib and azacitidine for higher risk myelodysplastic syndromes (University of California Hematologic Malignancies Consortium Study 1503).
Journal: Leukemia research
Published: March 18, 2025
CPX-351 plus gemtuzumab ozogamicin for relapsed/refractory acute myelogenous leukemia: a University of California Hematologic Malignancies Consortium trial.
Journal: Leukemia & lymphoma
Published: December 17, 2024
Evaluation of venous thromboembolism prophylaxis protocol in hematopoietic cell transplant patients.
Evaluation of venous thromboembolism prophylaxis protocol in hematopoietic cell transplant patients.
Journal: Bone marrow transplantation
Published: February 03, 2023
Association of geriatric measures and global frailty with cognitive decline after allogeneic hematopoietic cell transplantation in older adults.
Journal: Journal of geriatric oncology
Published: December 11, 2022
Patterns and Predictors of Functional Decline after Allogeneic Hematopoietic Cell Transplantation in Older Adults.
Journal: Transplantation and cellular therapy
Published: December 21, 2021
Inhibition of MET Signaling with Ficlatuzumab in Combination with Chemotherapy in Refractory AML: Clinical Outcomes and High-Dimensional Analysis.
Journal: Blood cancer discovery
Published: September 13, 2021
Long-term clinical outcomes of tisagenlecleucel in patients with relapsed or refractory aggressive B-cell lymphomas (JULIET): a multicentre, open-label, single-arm, phase 2 study.
Journal: The Lancet. Oncology
Published: April 06, 2021
Reductions in vancomycin and meropenem following the implementation of a febrile neutropenia management algorithm in hospitalized adults: An interrupted time series analysis.
Journal: Infection control and hospital epidemiology
Published: January 25, 2021
Ofatumumab, Etoposide, and Cytarabine Intensive Mobilization Regimen in Patients with High-risk Relapsed/Refractory Diffuse Large B-Cell Lymphoma Undergoing Autologous Stem Cell Transplantation.
Journal: Clinical lymphoma, myeloma & leukemia
Published: September 04, 2020
Efficacy of Venetoclax and Dexamethasone in Refractory IgM Primary Plasma Cell Leukemia with t(11;14) and TP53 Mutation: A Case Report and Literature Review.
Journal: Case reports in hematology
Published: September 02, 2020
Last Updated: 09/26/2026